Product
TYPHIM Vi
1 clinical trial
1 indication
Indication
MalariaClinical trial
Safety, Immunogenicity and Efficacy of Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in MaliStatus: Completed, Estimated PCD: 2021-07-30